(Q44094100)

29 November 2017

title

Torasemide in chronic heart failure: results of the TORIC study (English)

1 reference

29 November 2017

0 references

chronic heart failure

1 reference

Juan Cosín

1

1 reference

29 November 2017

Javier Díez

series ordinal

2

1 reference

29 November 2017

TORIC investigators

series ordinal

3

1 reference

29 November 2017

publication date

1 August 2002

1 reference

European Journal of Heart Failure

29 November 2017

published in

1 reference

29 November 2017

volume

4

1 reference

29 November 2017

issue

4

1 reference

29 November 2017

page(s)

507-513

1 reference

Guidelines for the diagnosis and treatment of chronic heart failure

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900122-8

Can physicians always explain the results of clinical trials? A case study of amlodipine in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900122-8

Benefits and risks of torasemide in congestive heart failure and essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900122-8

Torasemide (LUPRAC): a review of its pharmacological and clinical profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900122-8

Torasemide: a pharmacoeconomic review of its use in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900122-8

Torsemide inhibits aldosterone secretion in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900122-8

Anti-aldosteronergic effect of torasemide

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900122-8

Diuretic and vasodilating actions of torasemide

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900122-8

Preoperative assessment of patients with known or suspected coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900122-8

The Natural History of Congestive Heart Failure: The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900122-8

Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900122-8

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900122-8

Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900122-8

Torasemide. A review of its pharmacological properties and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900122-8

Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900122-8

7 January 2021

Clinical pharmacology of torasemide, a new loop diuretic

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900122-8

7 January 2021

Prescription-event monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900122-8

7 January 2021

Clinical and haemodynamic effects of long-term treatment with torasemide in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900122-8

7 January 2021

Torasemide, a new potent diuretic. Double-blind comparison with furosemide

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900122-8

7 January 2021

Torasemide Inhibits Angiotensin II–Induced Vasoconstriction and Intracellular Calcium Increase in the Aorta of Spontaneously Hypertensive Rats

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900122-8

7 January 2021

Chronic administration of aldosterone depresses baroreceptor reflex function in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900122-8

7 January 2021

10.1016/S1388-9842(02)00122-8

Identifiers

DOI

1 reference

29 November 2017

1 reference